Drug

Dextromethorphan/Bupropion Tablet AXS-05 clinical trials

Also written AXS-05.

studies test it: 16
open now: 3
in phase 3: 9
first study started: 2016

Keep track of what changes. Save the Dextromethorphan/Bupropion Tablet AXS-05 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

AXS-05 (dextromethorphan-bupropion): 4

Development codes

AXS-05: 11

Studies by the year they started

16 studies that test it; most in 2020 (3)

Studies that test Dextromethorphan/Bupropion Tablet AXS-05, by start year
Year	Studies
2016	1
2017	1
2018	2
2019	2
2020	3
2021	2
2022	1
2023	1
2024	1
2025	1
2026	1

By phase

A phase 1/2 study counts in both.

Phase 2: 7
Phase 3: 9
Phase 4: 1

What it is tested for

Each study’s main condition, where its own words name it.

Alzheimer Disease: 5
Depression: 4
Depressive Disorder, Major: 4
Tobacco Use Disorder: 1
Smoking Cessation: 1
Depressive Disorder, Treatment-Resistant: 1

Who runs them

Industry 14 · Other 2

Axsome Therapeutics, Inc. (14) · James Davis (1) · Roger McIntyre (1)

Often tested with

Tested in the same studies.

Bupropion (1)

Studies

Open first, then newest update. How each study uses Dextromethorphan/Bupropion Tablet AXS-05 is read from its arms, and is right about nine times in ten.